Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients

Dick Chan; Sandy Hamilton; K.A. Rye; A.J. Jenkins; G. Lambert; Gerald Watts

doi:10.1111/j.1463-1326.2010.01229.x

Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients

Dick Chan
, Sandy Hamilton
, K.A. Rye
, A.J. Jenkins
, G. Lambert
, Gerald Watts

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	752-756
Journal	Diabetes Obesity & Metabolism
Volume	12
DOIs	https://doi.org/10.1111/j.1463-1326.2010.01229.x
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/j.1463-1326.2010.01229.x

Cite this

@article{87f1b7c1d5ce42abaf3e751a95d3d2f7,

title = "Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients",

author = "Dick Chan and Sandy Hamilton and K.A. Rye and A.J. Jenkins and G. Lambert and Gerald Watts",

year = "2010",

doi = "10.1111/j.1463-1326.2010.01229.x",

language = "English",

volume = "12",

pages = "752--756",

journal = "Diabetes Obesity \& Metabolism",

issn = "1462-8902",

publisher = "John Wiley \& Sons",

}

TY - JOUR

T1 - Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients

AU - Chan, Dick

AU - Hamilton, Sandy

AU - Rye, K.A.

AU - Jenkins, A.J.

AU - Lambert, G.

AU - Watts, Gerald

PY - 2010

Y1 - 2010

U2 - 10.1111/j.1463-1326.2010.01229.x

DO - 10.1111/j.1463-1326.2010.01229.x

M3 - Article

C2 - 20649626

SN - 1462-8902

VL - 12

SP - 752

EP - 756

JO - Diabetes Obesity & Metabolism

JF - Diabetes Obesity & Metabolism

ER -